Gene Weaver is developing the next generation gene modification technology offering high efficiency and enhanced precision that aims to supersede the current industry standard editing techniques used across life sciences.
The interdisciplinary team, led by Recombinase Polymerase Amplification (RPA) technology inventor Dr Niall Armes, is employing a unique enzymatic system with the potential to transform gene editing.
Company Details
- Employees
- 7
- Founded
- 2023
- Address
- Cambridge, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.gene-weaver.co.uk
- Keywords
- Novel gene editing platform technology, Gene editing, gene modification, genetic medicine, biotherapeutic R&D.
- HQ
- Cambridge
Gene Weaver Ltd Questions
Gene Weaver Ltd's website is http://www.gene-weaver.co.uk
Gene Weaver Ltd's LinkedIn profile is https://uk.linkedin.com/company/gene-weaver-ltd
Gene Weaver Ltd has
7 employees.
View email and phone details for 7
employees at Gene Weaver Ltd.
Gene Weaver Ltd's industry is
Biotechnology Research
Gene Weaver Ltd's top competitors are
Altos Labs,
Cellcentric,
Arecor Therapeutics,
Isogenica,
Charles River Laboratories,
Vernalis,
Partitionbio Ltd,
Sapphiros Uk,
Isomerase,
Diagnostics For The Real World (Drw).
Gene Weaver Ltd's categories are Biotechnology Research
Gene Weaver Ltd's founding year is 2023
